|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/12 | (2006.01) |
| G01N 33/569 | (2006.01) | ||
| C12Q 1/37 | (2006.01) | ||
| G01N 33/50 | (2006.01) | ||
| G01N 33/566 | (2006.01) | ||
| G01N 33/68 | (2006.01) |
| (11) | Number of the document | 3031825 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16153819.4 |
| Date of filing the European patent application | 2009-03-13 | |
| (97) | Date of publication of the European application | 2016-06-15 |
| (45) | Date of publication and mention of the grant of the patent | 2019-07-24 |
| (46) | Date of publication of the claims translation | 2020-02-10 |
| (30) | Number | Date | Country code |
| 36723 P | 2008-03-14 | US |
| (72) |
Fernandez-Salas, Ester, US
Wang, Joanne, US
Garay, Patton E., US
Wong, Lina S., US
Hodges, D. Diane, US
Aoki, Kei Roger, US
|
| (73) |
ALLERGAN, INC.,
2525 Dupont Drive, Irvine, CA 92612,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Botulino toksino serotipo A aktyvumo imuninio tyrimo būdai |
| IMMUNO-BASED BOTULINUM TOXIN SEROTYPE A ACTIVITY ASSAYS |
| Payment date | Validity (years) | Amount | |
| 2025-02-10 | 17 | 347.00 EUR |
| 2026-03-13 |